New Cooperation Agreement with HERMES PHARMA

This is a mutually exclusive contractual arrangement under which Midas will represent HERMES PHARMA’s unique and user-friendly dosage forms and products into the US Market with initial focus on Dietary and Food Supplements as well as OTC drug products.

Midas and HERMES PHARMA will work together collaboratively to bring HERMES PHARMA’s suite of unique, user-friendly and innovative products to US clients with local, regional, and national market coverage.

Products will be offered and commercially sold to US clients in a business-to- business arrangement where the products may be white-labeled or branded in the clients’ own label for distribution within the US market.

Midas and HERMES PHARMA will also be offering customized formulations per the guidance of clients who choose to market and sell formulations that are tailored to the specific needs of US consumers (co-developments).

The initial focus will be on dietary and food supplements, then OTC products will be offered in due course.   

HERMES PHARMA Executive Statement, Dr. Thomas Hein, CEO of HERMES PHARMA: ”This strategic partnership brings together our development and manufacturing expertise of user-friendly dosage forms and the market insights and network of MIDAS PHARMACEUTICALS. I am excited about the opportunity and the growth this collaboration will bring to both companies and I am looking forward to making a lasting impact together.”

Tim Feuerstein, President of MIDAS PHARMACEUTICALS INC.: “This collaboration aligns perfectly with our strategic vision and long-term goals. By joining forces with HERMES PHARMA, we will broaden our portfolio of B2B services and expand our customer base. I am confident that this collaboration will yield remarkable results.”  


HERMES PHARMA is the leading expert in developing and manufacturing user-friendly oral dosage forms, including effervescent and chewable tablets, instant drinks, lozenges, orally disintegrating granules and the newly developed HERMES NutriCaps. As a contract development and manufacturing organization (CDMO), we offer customized services along the entire pharmaceutical value chain, from new product development and formulation to manufacturing and regulatory support. For more than 40 years, leading healthcare companies around the globe have worked with HERMES PHARMA to expand their pharmaceutical and nutraceutical product lines as well as to grow their brands.

Our sister company HERMES Arzneimittel has a rich portfolio of successful OTC brands and a history of more than a hundred years in pharmaceutical excellence. This heritage makes HERMES PHARMA a reliable and experienced partner who truly understands the challenges of its customers. 

About Midas Pharma

Midas Pharma is a pharmaceutical company based in Ingelheim, Germany, that offers products, services, and expertise along the entire pharmaceutical value chain ‑ from Starting Materials and Active Pharmaceutical Ingredients to market ready Finished Products and Devices. Since over three decades the family-owned company has successfully contributed to the Pharma sector and has step by step expanded its competencies. With more than 280 employees and 10 locations in all major pharmaceutical markets worldwide Midas Pharma has excellent local know-how, local contacts, and well-established networks in different pharmaceutical sectors (biological products, small molecules and medical devices). Thanks to many years of experience and extensive expertise, Midas Pharma has a proven track record of successfully supporting its customers in coordinating even complex pharmaceutical projects and creating significant added value.

Your Contact

Dr. Tim Feuerstein

Dr. Tim Feuerstein

Midas Pharmaceuticals, Inc.

300 Interpace Parkway, Suite 420
Parsippany, New Jersey 07054-1100

Telephone: +1 973 541 4911
Telefax:     +1 973 541 4914
Send E-Mail

Share this page